INSIGHTS ON QUALITY CONTROL
-
The Importance Of Having A Strong Reject Characterization Program
Discover how linking inspection results to systematic defect analysis strengthens data integrity, accelerates root cause resolution, and satisfies regulatory process knowledge requirements.
-
How Ergonomics And Cleaning Ease Reduce Repetitive Stress Injuries And Contamination In Pharmaceutical Lab Workflows
The repetitive nature of routine laboratory procedures can put technicians and scientists at risk for repetitive strain injury. Routine activities often include reoccurrence of the same movements over and over, which can take a toll on hands, wrists and shoulders and ultimately can lead to serious damage. Choosing the right tools can make all the difference.
-
Check Weighing For Pharmaceuticals: Back To The Basics
Dynamic checkweighing helps manufacturers confirm product weight in motion, catch filling errors early, remove noncompliant packages, and support regulatory compliance without interrupting production.
-
Accelerate Biologics Product Release With Seamless Viral Testing
Explore viral safety testing for biologics, focusing on prevention, detection, and removal strategies, updated regulatory guidance, and common challenges in unprocessed bulk testing.
-
De-Risking Automatic Visual Inspection (AVI) Through Integrated Validation7/30/2026
Aligning visual inspection systems with site standards prevents costly validation failures. Discover strategies to de-risk equipment startup.
-
Scaling Down For Success: Optimizing Single-Use Virus Filtration For Small-Scale Bioprocessing9/2/2026
Automation can bring greater consistency, product recovery, data capture, and operational efficiency to small-scale viral filtration once processes are sufficiently defined, helping gene therapy developers transition beyond highly manual workflows.
-
Build A Culture Of Clean To Elevate Your Cleanroom2/12/2026
Keeping your cleanroom spotless is vital for product quality and patient safety. Consider these important factors for how to build a culture of clean and how your cleanroom will benefit.
-
Ensuring Compliance For Virtual And Hybrid Pharmaceutical Companies10/16/2025
Proactive, risk-based oversight must be established to manage outsourced GXP activities. This requires a robust QMS and comprehensive quality agreements to safeguard product quality and data integrity.
-
Engineering Controls For Sterile Compounding — USP Requirements And Equipment Selection7/24/2026
Aligning compounding operations with USP <797> and <800> requires an integrated control strategy. Discover key criteria for cleanroom equipment selection.
QUALITY CONTROL SOLUTIONS
-
Discover the advantages of an intuitively simple HPLC system developed specifically for biopharmaceutical quality control laboratories.
-
Traditional bioburden testing (or microbial limit testing) takes several days to grow visible colonies of microorganisms, so identifying these and initiating corrective action takes longer. The Milliflex® Quantum system quantitatively detects microbial contamination in filterable samples in as little as a third of the time it takes with traditional plate-based monitoring methods. The Milliflex® Quantum system is based on fluorescent staining of all viable microorganisms, making emerging microcolonies visible to the system when they’re still too small to be seen with the naked eye. After rapid detection, the colonies can be reincubated to grow into visible colonies and be identified by any method—an approach that cleverly combines rapid and compendial bioburden testing.
-
Explore an extensive analytical chemistry and microbial testing compliant portfolio for pharmaceutical analysis and quality control (QC) from early-stage drug development to product release.
-
Discover a system that addresses the issues faced by Quality Control (QC) labs with first-time quality (FTQ) results, shortened release cycles, and fewer investigations.
-
Active bead release gives manufacturers precise control over T cell isolation timing, phenotype preservation, and workflow efficiency, eliminating multi-day passive dissociation delays.